BioSpace News Archive

Tetra Bio-Pharma Inc., a leader in cannabinoid-derived drug discovery and development announced that the Company has been granted a Health Canada Drug Establishment License to distribute REDUVO soft gel capsules in Canada.

Eagle Pharmaceuticals, Inc. announced the appointment of Luciana Borio, MD, to its Board of Directors.

Clearside Biomedical, Inc., a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced the resubmission of its New Drug Application to the U.S. Food and Drug Administration for XIPERETM for the treatment of macular edema associated with uveitis.

- BioXcel Therapeutics, Inc. (“BioXcel” or the “Company”) (NASDAQ: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced it will host a conference call and webcast on Monday, May 10, 2021 at 8:30 AM Eastern Time to discuss its first quarter 2021 operating and financial results.

HUTCHMED Limited announces that it completed the rolling submission of a New Drug Application to the U.S. Food and Drug Administration for surufatinib for the treatment of pancreatic and extra-pancreatic neuroendocrine tumors.

Alkermes plc (Nasdaq: ALKS) today announced plans to present clinical data and outcomes research from its psychiatry portfolio at three scientific conferences during Mental Health Awareness Month in May.

Gemini Therapeutics, Inc. (Nasdaq: GMTX), a clinical stage precision medicine company developing innovative treatments for genetically defined age-related macular degeneration (AMD) and linked ocular disorders, today announced the appointment of Georges Gemayel, Ph. D., as the Chair of the Company’s Board of Directors.

Blood components such as platelet and plasma play a critical role on in the treatment of a number of diseases or while surgical interventions or in case a patient needs to be revived from active bleeding.

Transparency Market Research has published a new report on the neurostimulation devices market for the forecast period of 2019 - 2027.

Addex Therapeutics Ltd, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced that it will issue its Q1 2021 financial results on Wednesday May 5, 2021.